The Discounted Cash Flow (DCF) valuation of Spero Therapeutics Inc (SPRO) is (97.47) USD. With the latest stock price at 2.37 USD, the upside of Spero Therapeutics Inc based on DCF is -4212.6%.
Based on the latest price of 2.37 USD and our DCF valuation, Spero Therapeutics Inc (SPRO) is a sell. selling SPRO stocks now will result in a potential gain of 4212.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 6.2% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | (657.49) - (53.39) | (97.47) |
| Upside | -27842.3% - -2352.6% | -4212.6% |